Articles by Maureen Martino
Aeras, CNBG team on TB vaccine deal
Non-profit developer Aeras is teaming up with the China National Biotec Group (CNBG) to jointly develop new tuberculosis vaccines. Financial details of the deal were not disclosed. CNBG and...
Oncothyreon awaits pivotal data on Stimuvax
Oncothyreon ($ONTY) execs are expecting interim results from a late-stage study of lung cancer vaccine Stimuvax sometime this quarter. Results from the 1,514-person trial, which is being conducted by...
As India nears polio eradication, researchers ponder new vaccines
Today marks the end of the first year in which India had zero reported cases of polio, a major milestone for a country that's pushed hard in recent years to eliminate the disease. Pakistan,...
Microtest to manufacture ImmusanT's celiac vaccine
Microtest Laboratories will manufacture Nexvax2 for a mid-stage trial of ImmusanT's vaccine as a treatment for celiac disease. ImmunsanT secured $20 million in venture captial funding from Vatera
ImmunoCellular starts Phase II trial of brain cancer vaccine
Wake Forest Baptist Medical Center is heralding its involvement in a new Phase II trial of ImmunoCellular Therapeutics' ICT-107. The cancer vaccine, which we recently chose as one of 10 promising
Vaccine combo shows early promise against AIDS
A new AIDS vaccine that combines two experimental therapies has shown promise in monkeys. The animals were given a vaccine developed by Johnson & Johnson ($JNJ) subsidiary Crucell combined with a...
GSK's genital herpes vaccine gets disappointing results
A trial of 8,323 women revealed that a vaccine designed to prevent genital herpes was only able to partially protect women from one strain of the virus, according to research published in The New
Preclinical data in hand, Tetragenetics seeks partners for vaccine platform
Cambridge, MA-based Tetragenetics has reported preclinical results that show its nanoparticle-based influenza vaccine protected mice from a particularly virulent strain of H5N1. Company founder and...
Study: Most girls who get HPV vax say they see need to practice safe sex
According to a study published in Archives of Pediatrics & Adolescent Medicine, most girls who got the HPV shot understood that they still needed to practice safe sex to prevent other diseases.
FDA approves Pfizer's Prevnar 13 for adults over 50
Pfizer ($PFE) has won a much-anticipated FDA approval for Prevnar 13 for older adults to prevent pneumonia and other diseases caused by 13 Streptococcus pneumoniae serotypes contained in the vaccine....
